Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer.
作者信息
Bellmunt Joaquim, Rosenberg Jonathan E, Choueiri Toni K
出版信息
Eur Urol. 2009 Oct;56(4):606-8. doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22.
PMID:19635642
Abstract
摘要
相似文献
1
Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer.去势抵抗性前列腺癌新型药物测试的最新进展与困境
Eur Urol. 2009 Oct;56(4):606-8. doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22.
2
Castration-resistant prostate cancer: descriptive yet pejorative?去势抵抗性前列腺癌：描述性但带有贬义？
J Clin Oncol. 2010 Aug 10;28(23):e408. doi: 10.1200/JCO.2010.28.7664. Epub 2010 Jun 14.
3
Castration-resistant prostate cancer--hormone therapy redux.去势抵抗性前列腺癌——激素疗法的再次应用
J Clin Oncol. 2010 Mar 20;28(9):1447-9. doi: 10.1200/JCO.2009.25.3781. Epub 2010 Feb 16.
4
5
Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer.持续靶向雄激素受体信号传导：转移性去势抵抗性前列腺癌的一种合理且有效的治疗策略。
Eur J Cancer. 2011 Sep;47 Suppl 3:S189-94. doi: 10.1016/S0959-8049(11)70164-2.
6
[Cancer of the prostate. What treatment, for which patient, in 1986?].[前列腺癌。1986年，针对哪些患者采用何种治疗方法？]
Ann Urol (Paris). 1986;20(2):79-81.
7
Physiologic basis of endocrine therapy for prostatic cancer.
Urol Clin North Am. 1991 Feb;18(1):1-13.
8
Compliance with hormonal treatment for prostate cancer.
Br J Hosp Med. 1996;55(6):359-66.
9
Maximal androgen blockade versus total androgen suppression.最大雄激素阻断与全雄激素抑制
Acta Urol Belg. 1997 Mar;65(1):49-54.
10
Novel secondary hormonal therapy in advanced prostate cancer: an update.晚期前列腺癌的新型二线激素治疗：最新进展
Curr Opin Urol. 2009 May;19(3):315-21. doi: 10.1097/MOU.0b013e328329b73a.
引用本文的文献
1
Castration-resistant prostate cancer: new science and therapeutic prospects.去势抵抗性前列腺癌：新科学和治疗前景。
Ther Adv Med Oncol. 2010 May;2(3):189-207. doi: 10.1177/1758834009359769.
Zotero 插件